Linda Nalotto

Padova, 35128, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study.

Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study.

Journal: Journal of clinical medicine

Published: March 29, 2019

Case Report: Paradoxical acrodermatitis of Hallopeau-like eruption following anti-IL-17 therapy.

Case Report: Paradoxical acrodermatitis of Hallopeau-like eruption following anti-IL-17 therapy.

Journal: F1000Research

Published: March 11, 2019

Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies.

Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies.

Journal: Clinical reviews in allergy & immunology

Published: August 25, 2018

Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies.

Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies.

Journal: Clinical reviews in allergy & immunology

Published: March 08, 2018

The Management of Systemic Lupus Erythematosus (SLE) Patients in Remission.

The Management of Systemic Lupus Erythematosus (SLE) Patients in Remission.

Journal: The Israel Medical Association journal : IMAJ

Published: August 09, 2017

Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus.

Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus.

Journal: Arthritis care & research

Published: March 17, 2016

17-β-estradiol affects BLyS serum levels and the nephritogenic autoantibody network accelerating glomerulonephritis in NZB/WF1 mice.

17-β-estradiol affects BLyS serum levels and the nephritogenic autoantibody network accelerating glomerulonephritis in NZB/WF1 mice.

Journal: Lupus

Published: March 25, 2015

Prolonged remission in Caucasian patients with SLE: prevalence and outcomes.

Prolonged remission in Caucasian patients with SLE: prevalence and outcomes.

Journal: Annals of the rheumatic diseases

Published: January 23, 2015

The body against self: autoinflammation and autoimmunity.

The body against self: autoinflammation and autoimmunity.

Journal: The Israel Medical Association journal : IMAJ

Published: December 03, 2014

Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation.

Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation.

Journal: Auto- immunity highlights

Published: September 03, 2014

Premature coronary heart disease in SLE: can we prevent progression?

Premature coronary heart disease in SLE: can we prevent progression?

Journal: Lupus

Published: October 08, 2013

Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature.

Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature.

Journal: Immunologic research

Published: April 11, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026